Effectiveness and Safety of Atazanavir Use for the Treatment of Children and Adolescents Living With HIV: A Systematic Review

BACKGROUND: Atazanavir/ritonavir is recommended as a preferred second-line antiretroviral regimen in children older than 3 months, alternatively to lopinavir/ritonavir. We performed a systematic review to assess safety and effectiveness of atazanavir use in children and adolescents. METHODS: We sear...

Descripción completa

Detalles Bibliográficos
Autores principales: Saint-Lary, Laura, Dassi Tchoupa Revegue, Marc Harris, Jesson, Julie, Renaud, Françoise, Penazzato, Martina, Townsend, Claire L., O'Rourke, John, Leroy, Valériane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168429/
https://www.ncbi.nlm.nih.gov/pubmed/35676899
http://dx.doi.org/10.3389/fped.2022.913105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168429/
https://www.ncbi.nlm.nih.gov/pubmed/35676899
http://dx.doi.org/10.3389/fped.2022.913105

Ejemplares similares